NasdaqGM - Nasdaq Real Time Price USD

LifeMD, Inc. (LFMD)

8.26

+0.10

+(1.23%)

At close: May 9 at 4:00:00 PM EDT

8.09

-0.17

(-2.06%)

After hours: May 9 at 6:24:21 PM EDT

LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance

Total revenues increased 49% year-over-year to $65.7 million with telehealth revenue up 70%Adjusted EBITDA increased to $8.7 million from $0.1 million in the year-ago periodTelehealth adjusted EBITDA increased to $5.3 million from a loss of $1.3 million in the year-ago periodGAAP net income of $0.6 million or $0.01 per diluted share, delivering first-ever quarter of positive GAAP EPSRaising full-year 2025 guidance for both total revenues and adjusted EBITDA, reflecting strong year-to-date perfor

GlobeNewswire 4 days ago

LFMD
+1.23%

LFMDP
Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead

The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only getting wider.

The Wall Street Journal 10 days ago

LLY

LFMD
+1.23%

LFMDP
3 High-Ownership Growth Stocks With Earnings Up To 105%

As the U.S. stock market experiences a period of cautious optimism, with indices like the Dow Jones and S&P 500 extending their winning streaks, investors are closely monitoring earnings reports and potential tariff changes that could impact economic growth. In this environment, companies with high insider ownership often attract attention for their alignment of interests between management and shareholders, particularly when these firms demonstrate significant earnings growth.

Simply Wall St. 11 days ago

LFMD
+1.23%

LFMDP

DDL
LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announced plans to offer broad, affordable, and streamlined access to Wegovy® (semaglutide) through NovoCare® Pharmacy. This integration offers a simplified pathway for cash-pay patients to access all FDA-approved dose strengths of Wegovy® directly within LifeMD’s virtual care platform. LifeMD’s weight management program is one of the fastest-growing cash-pay offerings i

GlobeNewswire 11 days ago

LFMD
+1.23%

LFMDP
LifeMD to Report First Quarter 2025 Financial Results on May 6

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on May 6, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Tuesday, May 6thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-225-9448International Dial-In:203-518-9708Confere

GlobeNewswire 12 days ago

LFMD
+1.23%

LFMDP
LifeMD Acquires Women’s Health Provider Optimal Human Health MD to Accelerate Entry into the Women’s Health Market

Acquisition Establishes Clinical and Operational Foundation for LifeMD’s Comprehensive Women’s Health Offering, Launching Summer 2025NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the acquisition of key assets from Optimal Human Health MD (“Optimal”), a nationwide women’s health virtual care provider. This strategic acquisition marks LifeMD’s official entry into the women’s health market and establish

GlobeNewswire 12 days ago

LFMD
+1.23%

LFMDP
LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs

LifeMD’s virtual care services now available to over 21 million Medicare Part B beneficiaries in 26 states, with 49-state access to qualifying services expected by the end of Q2NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced expanded acceptance of insurance to Medicare beneficiaries for qualifying care. Initially available to more than 21 million Medicare Part B beneficiaries in 26 states, the company

GlobeNewswire 23 days ago

LFMD
+1.23%

LFMDP
Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform

Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its telehealth platform.

Investor's Business Daily last month

LFMD
+1.23%

LFMDP

TDOC
LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pha

GlobeNewswire last month

LFMD
+1.23%

LFMDP
Retail investors who have a significant stake must be disappointed along with institutions after LifeMD, Inc.'s (NASDAQ:LFMD) market cap dropped by US$29m

Key Insights LifeMD's significant retail investors ownership suggests that the key decisions are influenced by...

Simply Wall St. last month

LFMD
+1.23%

LFMDP
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on April 15, 2025, to holders of record at the close of business on April 4, 2025. About LifeMD, Inc. LifeMD® is a leading provider of

GlobeNewswire last month

LFMD
+1.23%

LFMDP
High Growth Tech Stocks In The US With Promising Potential

Over the last 7 days, the United States market has dropped 4.1%, yet it remains up by 6.6% over the past year with earnings expected to grow by 14% per annum in the coming years. In this context, identifying high growth tech stocks that align with these positive earnings projections can be crucial for investors looking to capitalize on technological advancements and market resilience.

Simply Wall St. last month

LFMD
+1.23%

LFMDP

AAOI
Insider-Led Growth Companies To Watch Now

As the U.S. stock market grapples with political and economic uncertainty, leading to a correction in major indices like the S&P 500 and Nasdaq Composite, investors are increasingly seeking stability amidst volatility. In such times, growth companies with high insider ownership can be particularly appealing, as they often signal strong alignment between management and shareholder interests—a crucial factor when navigating turbulent market conditions.

Simply Wall St. last month

LFMD
+1.23%

LFMDP

APP
LifeMD Full Year 2024 Earnings: Beats Expectations

LifeMD ( NASDAQ:LFMD ) Full Year 2024 Results Key Financial Results Revenue: US$212.5m (up 39% from FY 2023). Net loss...

Simply Wall St. last month

LFMD
+1.23%

LFMDP
LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions

LifeMD Inc (LFMD) reports a 43% revenue increase and unveils plans for new product launches and Medicare offerings amid market challenges.

GuruFocus.com last month

LFMD
+1.23%

LFMDP
LifeMD Reports Fourth Quarter 2024 Results

Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 millionTelehealth adjusted EBITDA increased 396% to $5.9 millionFull-year cash flow from operations increased 99% to $17.5 million and generated positive full-year net cash flowExited 2024 with over $35 million in cashIntroduces 2025 guidance for consolidated revenue of $265 million to $275 million and consolidated adjusted EBITDA of $30 million to $32 million C

GlobeNewswire last month

LFMD
+1.23%

LFMDP
LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound

NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced it is integrating with LillyDirect pharmacy provider, Gifthealth, to offer streamlined access of single-dose vials of Lilly’s prescription obesity treatment Zepbound® (tirzepatide) to eligible LifeMD patients. Integration with the LillyDirect® self-pay pharmacy channel will provide a seamless solution to a patient’s Zepbound fulfillment journey while cont

GlobeNewswire 2 months ago

LFMD
+1.23%

LFMDP
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum

NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the KeyBanc Capital Markets Healthcare Forum being held virtually on March 18-19, 2025. Management will participate in a fireside chat on Tuesday, March 18th at 11:15 a.m. Eastern time and will hold one-on-one meetings throughout the conference. About LifeMD, Inc.LifeMD® is a leading provider of virtual primary care. LifeMD offers tel

GlobeNewswire 2 months ago

LFMD
+1.23%

LFMDP
LifeMD to Report Fourth Quarter 2024 Financial Results on March 10

NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on March 10, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Monday, March 10thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-225-9448International Dial-In:203-5

GlobeNewswire 2 months ago

LFMD
+1.23%

LFMDP
LifeMD® Announces Entry Into the Behavioral Health Market

Expansion to Include Teletherapy, Psychiatry and Medication Management Behavioral Health Offering to be Led by Industry Veteran Julian Cohen NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its expansion into the behavioral health market. This strategic move broadens LifeMD’s service offerings to include teletherapy, psychiatry and medication management for common mental health conditions.LifeMD’s behavi

GlobeNewswire 2 months ago

LFMD
+1.23%

LFMDP

Performance Overview

Return	LFMD	S&P 500 (^GSPC)
YTD	+66.87%	-3.77%
1-Year	-11.18%	+8.55%
3-Year	+293.33%	+41.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

LifeMD, Inc. (LFMD)

LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance

Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead

3 High-Ownership Growth Stocks With Earnings Up To 105%

LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients

LifeMD to Report First Quarter 2025 Financial Results on May 6

LifeMD Acquires Women’s Health Provider Optimal Human Health MD to Accelerate Entry into the Women’s Health Market

LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs

Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform

LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference

Retail investors who have a significant stake must be disappointed along with institutions after LifeMD, Inc.'s (NASDAQ:LFMD) market cap dropped by US$29m

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

High Growth Tech Stocks In The US With Promising Potential

Insider-Led Growth Companies To Watch Now

LifeMD Full Year 2024 Earnings: Beats Expectations

LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions

LifeMD Reports Fourth Quarter 2024 Results

LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound

LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum

LifeMD to Report Fourth Quarter 2024 Financial Results on March 10

LifeMD® Announces Entry Into the Behavioral Health Market

Performance Overview